MAPT and Alzheimer disease: Taken together, the activation of the NLRP3 inflammasome and ensuing production of excessive IL-1β and cleaved GSDMD in microglia and neurons may link the AD-associated pathologies of Aβ and tau aggregation, synaptic loss, and neuronal death.